| Companies sponsors |
GlaxoSmithKline (belantamab mafodotin) |
| Others |
Department of Health and Social Care |
| |
Health Technology Wales |
| |
NHS England |
| Patient carer groups |
Myeloma UK |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| |
UK Myeloma Society |
| Assessment group |
Centre for Reviews and Dissemination and Centre for Health Economics, University of York |
| Associated public health groups |
None |
| Comparator companies |
AbbVie (dexamethasone) (confidentiality agreement signed, participating) |
| |
Bristol Myers Squibb Pharmaceuticals (lenalidomide, pomalidomide) (confidentiality agreement signed, participating) |
| |
Menarini Stemline UK (selinexor) (confidentiality agreement signed, participating) |
| |
Takeda UK (ixazomib) (confidentiality agreement signed, participating) |
| |
ADVANZ Pharma (dexamethasone, lenalidomide) (confidentiality agreement not signed, not participating) |
| |
Amarox (lenalidomide) (confidentiality agreement not signed, not participating) |
| |
Amgen (carfilzomib) (confidentiality agreement not signed, not participating) |
| |
AS Kalceks (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Aspen (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Aspire Pharma (bortezomib, dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Aurobindo Pharma (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Bausch & Lomb U.K (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Biocon Pharma UK (lenalidomide) (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Dr. Reddy's Laboratories UK (bortezomib) (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Glenmark Pharmaceuticals Europe (dexamethasone, lenalidomide) (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Hameln pharma (dexamethasone) (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Hospira UK (dexamethasone) (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Janssen-Cilag (bortezomib, daratumumabl) (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Krka UK (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Martindale Pharma, an Ethypharm Group Company (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Medac GmbH (bortezomib) (confidentiality agreement not signed, not participating) |
| |
MSN Laboratories Europe (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Mylan (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
| |
Novartis Pharmaceuticals UK (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Panpharma UK (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
ParaPharm Development (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Pfizer (bortezomib, elranatamab) (confidentiality agreement not signed, not participating) |
| |
Piramal Critical Care (lenalidomide) (confidentiality agreement not signed, not participating) |
| |
Ranbaxy UK Limited a Sun (confidentiality agreement not signed, not participating) |
| |
Pharmaceutical Company (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
| |
Rayner Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Rosemont Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Sandoz (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
| |
Sanofi (dexamethasone, isatuximab) (confidentiality agreement not signed, not participating) |
| |
Santen UK (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Synchrony Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Teva UK (dexamethasone, lenalidomide) (confidentiality agreement not signed, not participating) |
| |
Thame Laboratories (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Thea Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Thornton & Ross (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
| |
Tillomed Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Wockhardt UK (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Zentiva (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
| |
ZR Pharma & GmBH (panobinostat) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
None |